<p>Total collagen in the (A) skin or (B) lungs of mice challenged daily with subcutaneous bleomycin and treated daily with either BMP-7 (hatched bars) or vehicle control (filled bars) (mean±S.E.M. of n = 8 mice/group). JE/CCL2 protein levels were measured by luminex in (C) skin and (D) lung homogenates of subcutaneous bleomycin-challenged mice. Each data point represents one animal, with bars representing the mean. For differences in Bleomycin challenged in comparison to naïve control groups * indicates p<0.05, **p<0.01, ***p<0.005 statistical significance.</p
<p>Animals were treated with 0.1 mg/kg bleomycin (n = 9) or vehicle (n = 5) on six consecutive days ...
(A) Chemical structure of KIRA7. (B) Schematic of the KIRA7 prevention regimen. Mice were exposed to...
The murine bleomycin (BLM)-induced fibrosis model is the most widely used in systemic sclerosis (SSc...
<p>In (A) mice were treated as described in Fig. 5A followed by harvest of the right lung for a Sirc...
<p>The numbers of BALF inflammatory cells increased after either a single (<b>A</b>) or repetitive (...
<p>(<b>A</b>) On day 21 after bleomycin treatment, lungs from control sera or anti-asialo GM1 treate...
<p>The CSF-1 receptor inhibitor BLZ945 (200 mg/kg, open circles), vehicle (20% Captisol) (closed cir...
<p>Mice were treated according to the schematic shown in Fig. 5A. Mice lungs were harvested at Day 1...
Bleomycin treatment produced dose-dependent changes in lung collagen content and in several measurab...
<p>Mouse lung fibroblasts from control animals (A) were stimulated with TGF-β1 (5 ng/ml) alone or in...
<p>A. Histological analysis of lungs of vaccinia vaccinated and mock (PBS) vaccinated mice following...
<p>Wild type (WT), TMPRSS4 deficient (KO) and haplodeficient (HT) mice were instilled with Bleomycin...
<p>C57Bl/6J mice had saline (n = 5 mice) or bleomycin instilled intra-tracheally (i.t.) on Day 0 and...
Bone morphogenic protein (BMP)-7 is a member of the BMP family which are structurally and functional...
<p>Comparison of the lung architecture in C57Bl/6 mice after BLM instillation (21st day of the exper...
<p>Animals were treated with 0.1 mg/kg bleomycin (n = 9) or vehicle (n = 5) on six consecutive days ...
(A) Chemical structure of KIRA7. (B) Schematic of the KIRA7 prevention regimen. Mice were exposed to...
The murine bleomycin (BLM)-induced fibrosis model is the most widely used in systemic sclerosis (SSc...
<p>In (A) mice were treated as described in Fig. 5A followed by harvest of the right lung for a Sirc...
<p>The numbers of BALF inflammatory cells increased after either a single (<b>A</b>) or repetitive (...
<p>(<b>A</b>) On day 21 after bleomycin treatment, lungs from control sera or anti-asialo GM1 treate...
<p>The CSF-1 receptor inhibitor BLZ945 (200 mg/kg, open circles), vehicle (20% Captisol) (closed cir...
<p>Mice were treated according to the schematic shown in Fig. 5A. Mice lungs were harvested at Day 1...
Bleomycin treatment produced dose-dependent changes in lung collagen content and in several measurab...
<p>Mouse lung fibroblasts from control animals (A) were stimulated with TGF-β1 (5 ng/ml) alone or in...
<p>A. Histological analysis of lungs of vaccinia vaccinated and mock (PBS) vaccinated mice following...
<p>Wild type (WT), TMPRSS4 deficient (KO) and haplodeficient (HT) mice were instilled with Bleomycin...
<p>C57Bl/6J mice had saline (n = 5 mice) or bleomycin instilled intra-tracheally (i.t.) on Day 0 and...
Bone morphogenic protein (BMP)-7 is a member of the BMP family which are structurally and functional...
<p>Comparison of the lung architecture in C57Bl/6 mice after BLM instillation (21st day of the exper...
<p>Animals were treated with 0.1 mg/kg bleomycin (n = 9) or vehicle (n = 5) on six consecutive days ...
(A) Chemical structure of KIRA7. (B) Schematic of the KIRA7 prevention regimen. Mice were exposed to...
The murine bleomycin (BLM)-induced fibrosis model is the most widely used in systemic sclerosis (SSc...